Pharmacodynamics of midodrine, an antihypotensive agent.
Midodrine is an orally active adrenergic agonist useful in the treatment of hypotension. We have investigated the pharmacodynamics of its active metabolite after oral midodrine therapy in nine patients with severe orthostatic hypotension. Peak plasma levels of the metabolite were reached in 60 to 90 minutes and ranged from 25 to 56 ng/ml. The mean values for distribution volume, plasma clearance, and t1/2 were 4.0 L/kg, 23 ml/min/kg, and 2.1 hours, respectively. Heart rate increased after 5 to 10 mg doses and the increases were statistically significant (P less than 0.05) at 120 minutes. An apparent increase in blood pressure was not statistically significant. The patients said that they felt better.
P K
PK
Zachariah
D C
DC
Bloedow
T P
TP
Moyer
S G
SG
Sheps
A
A
Schirger
R D
RD
Fealey
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002853:Chromatography, Liquid; D004298:Dopamine / Q000097:blood; D004837:Epinephrine / Q000097:blood; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D008879:Midodrine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D009638:Norepinephrine / Q000097:blood; D012791:Shy-Drager Syndrome / Q000188:drug therapy
D004983:Ethanolamines; C006146:ST 1059; D008879:Midodrine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine